Ovid Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	94.06	13.15	26.3	27.04	44.87	187.8
Short-Term Investments	61.46	56.48	26.77	78.79	84.13	-
Cash & Short-Term Investments	155.52	69.64	53.08	105.83	129	187.8
Cash Growth	261.71%	31.20%	-49.85%	-17.96%	-31.31%	160.71%
Other Current Assets	4.62	4.73	2.87	3.76	2.38	2.68
Total Current Assets	160.15	74.37	55.94	109.6	131.38	190.48
Net Property, Plant & Equipment	11.52	11.86	13.23	14.66	16.07	0.24
Long-Term Investments	52.04	62.77	20.97	17.63	5.62	1.63
Other Long-Term Assets	1.93	1.93	2.02	2.14	2.19	2.19
Total Assets	225.63	150.93	92.17	144.03	155.27	194.55
Accounts Payable	8.88	1.96	3.19	3.7	1.95	7.13
Accrued Expenses	5.41	4.9	5.99	6.52	4.5	7.67
Current Portion of Leases	1.46	1.43	1.34	1.25	0.53	-
Total Current Liabilities	15.75	8.29	10.52	11.47	6.99	14.8
Long-Term Leases	11.61	11.99	13.42	14.76	16	-
Other Long-Term Liabilities	-	-	-	30	-	-
Total Long-Term Liabilities	11.61	11.99	13.42	44.76	16	-
Total Liabilities	27.36	20.27	23.94	56.23	22.99	14.8
Preferred Stock	-	-	-	-	0	0
Common Stock	0.17	0.13	0.07	0.07	0.07	0.07
Additional Paid-in Capital	537.23	452.45	372.49	365.59	357.77	351.03
Accumulated Other Comprehensive Income	-0.42	-0.2	-0.04	0	-0.04	-
Retained Earnings	-338.7	-321.71	-304.3	-277.87	-225.53	-171.36
Shareholders' Equity	198.27	130.66	68.23	87.8	132.27	179.75
Total Liabilities & Equity	225.63	150.93	92.17	144.03	155.27	194.55
Total Debt	13.07	13.42	14.76	16	16.54	0
Net Cash (Debt)	142.45	56.22	38.32	89.83	112.47	187.8
Net Cash Growth	153.40%	46.70%	-57.34%	-20.13%	-40.11%	160.71%
Net Cash Per Share	1.58	0.76	0.54	1.27	1.60	2.76
Book Value	198.27	130.66	68.23	87.8	132.27	179.75
Book Value Per Share	2.20	1.77	0.96	1.24	1.88	2.64
Tangible Book Value	198.27	130.66	68.23	87.8	132.27	179.75
Tangible Book Value Per Share	2.20	1.77	0.96	1.24	1.88	2.64

SEC Filings: 10-K · 10-Q